Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Gastritis-I: Introduction and Types01:27

Gastritis-I: Introduction and Types

2.9K
Gastritis, defined by the inflammation or irritation of the stomach lining or gastric mucosa, manifests in several distinct forms: acute, chronic, reactive, and a specific subtype known as autoimmune metaplastic atrophic gastritis.
Acute gastritis presents as a sudden inflammation triggered by various stressors to the stomach lining, such as exposure to corrosive agents, local irritants like aspirin and other NSAIDs, alcohol consumption, radiation therapy, physical trauma, severe burns, sepsis,...
2.9K
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

1.6K
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
1.6K
Gastritis III: Clinical Manifestations and Management01:23

Gastritis III: Clinical Manifestations and Management

1.5K
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
1.5K
Peptic Ulcer Disease II: Pathophysiology01:28

Peptic Ulcer Disease II: Pathophysiology

2.4K
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
2.4K
Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

593
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
593
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

987
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
987

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sexual dimorphism in the association of circulating TAM receptors-ligands with MASLD-related fibrosis.

JHEP reports : innovation in hepatology·2026
Same author

Hierarchical organ aging signatures from routine abdominal CT add incremental disease risk stratification beyond blood biomarkers.

medRxiv : the preprint server for health sciences·2026
Same author

Extracellular vesicles in fatty liver promote a metastatic tumor microenvironment.

Cell metabolism·2026
Same author

The ULK1-NCOA3 axis restrains de novo lipogenesis and prevents diet-induced steatohepatitis and fibrosis in mice.

The Journal of clinical investigation·2026
Same author

Closing the Osteoporosis Care Gap: System-Level Fracture Liaison Service Implementation and a Patient Education Intervention in an Open Health System.

Cureus·2026
Same author

Practice changing RCT design and rationale: Abbreviated MRI plus AFP <i>vs.</i> ultrasound plus AFP for HCC surveillance in cirrhosis (PREMIUM study).

JHEP reports : innovation in hepatology·2026

Related Experiment Video

Updated: Mar 7, 2026

Mouse- and Human-derived Primary Gastric Epithelial Monolayer Culture for the Study of Regeneration
11:48

Mouse- and Human-derived Primary Gastric Epithelial Monolayer Culture for the Study of Regeneration

Published on: May 7, 2018

11.0K

Autoimmune atrophic gastritis: current perspectives.

Artem Minalyan1, Jihane N Benhammou1, Aida Artashesyan1

  • 1Division of Gastroenterology, Hepatology and Parenteral Nutrition.

Clinical and Experimental Gastroenterology
|February 23, 2017
PubMed
Summary
This summary is machine-generated.

The Updated Sydney System classifies atrophic gastritis into multifocal and corpus-predominant types. Autoimmune metaplastic atrophic gastritis (AMAG) is a key focus, distinct from H. pylori-induced gastritis.

Keywords:
autoimmune gastritisgastric carcinoidpernicious anemia

More Related Videos

Preparation of Mouse Pituitary Immunogen for the Induction of Experimental Autoimmune Hypophysitis
10:52

Preparation of Mouse Pituitary Immunogen for the Induction of Experimental Autoimmune Hypophysitis

Published on: December 17, 2010

15.1K
An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
06:35

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis

Published on: February 8, 2019

7.7K

Related Experiment Videos

Last Updated: Mar 7, 2026

Mouse- and Human-derived Primary Gastric Epithelial Monolayer Culture for the Study of Regeneration
11:48

Mouse- and Human-derived Primary Gastric Epithelial Monolayer Culture for the Study of Regeneration

Published on: May 7, 2018

11.0K
Preparation of Mouse Pituitary Immunogen for the Induction of Experimental Autoimmune Hypophysitis
10:52

Preparation of Mouse Pituitary Immunogen for the Induction of Experimental Autoimmune Hypophysitis

Published on: December 17, 2010

15.1K
An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
06:35

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis

Published on: February 8, 2019

7.7K

Area of Science:

  • Gastroenterology
  • Histopathology
  • Oncology

Background:

  • No universal classification for gastritis exists, with the Sydney System (1990) and its 1994 update being widely adopted.
  • The discovery of Helicobacter pylori in 1982 significantly impacted gastritis classification.
  • The Updated Sydney System revised distinctions between atrophic and nonatrophic gastritis, incorporating visual grading.

Purpose of the Study:

  • To review the etiology, epidemiology, pathogenesis, diagnosis, clinical manifestations, and treatment of autoimmune metaplastic atrophic gastritis (AMAG).
  • To highlight the distinction between AMAG and environmental metaplastic atrophic gastritis, despite overlapping features.
  • To emphasize the role of metaplasia as a key histological characteristic in atrophic gastritis.

Main Methods:

  • Review of existing literature on gastritis classification and autoimmune metaplastic atrophic gastritis.
  • Analysis of the Updated Sydney System's categorization of atrophic gastritis.
  • Discussion of diagnostic criteria and clinical management strategies for AMAG.

Main Results:

  • Atrophic gastritis is classified into multifocal (H. pylori, environmental) and corpus-predominant (autoimmune) types under the Updated Sydney System.
  • Autoimmune metaplastic atrophic gastritis (AMAG) is characterized by metaplasia, similar to environmental forms.
  • Helicobacter pylori remains the most prevalent cause of gastritis globally.

Conclusions:

  • The Updated Sydney System provides a framework for classifying atrophic gastritis, distinguishing autoimmune and environmental etiologies.
  • AMAG requires specific consideration due to its distinct pathogenesis and management, despite histological similarities with other forms.
  • Accurate classification and understanding of AMAG are crucial for effective patient care and research.